摘要
近年来NLR因其易于获取及价格低廉从而广泛引起广大临床工作者的兴趣,并取得了显著成果。近年来越来越多的研究证实,NLR的升高与恶性肿瘤患者的不良预后相关。本文就NLR在肾细胞癌、膀胱癌、前列腺癌、非小细胞肺癌、结直肠癌中的最新研究进展进行综述。
In recent years, NLR has aroused the interest of clinicians because of its easy access and low price, and has achieved remarkable results. In recent years, more and more studies have confirmed that elevated NLR is associated with poor prognosis in patients with malignant tumors. This article re-views the latest research progress of NLR in renal cell carcinoma, bladder cancer, prostate cancer, non-small cell lung cancer, and colorectal cancer.
出处
《临床医学进展》
2023年第3期2926-2931,共6页
Advances in Clinical Medicine